Application of the CDK9 inhibitor FIT-039 for the treatment of KSHV-associated malignancy

Sakamoto, T; Ajiro, M; Watanabe, A; Matsushima, S; Ueda, K; Hagiwara, M

Ajiro, M; Hagiwara, M (通讯作者),Kyoto Univ, Grad Sch Med, Dept Anat & Dev Biol, Bldg C, 3Rd Floor, Yoshida Konoe Cho, Sakyo Ku, Kyoto 6068501, Japan.;Ajiro, M (通讯作者),Kyoto Univ, Grad Sch Med, Dept Drug Discovery Med, Kyoto 6068501, Japan.

BMC CANCER, 2023; 23 (1):

Abstract

Chronic infection with Kaposi's sarcoma-associated herpes virus (KSHV) in B lymphocytes causes primary effusion lymphoma (PEL), the most aggressive fo......

Full Text Link